and eluted from anti-CGAT-Sepharose columns, while DBA/1 T~F specific for the related polymer L-glutamic acidS°-L-alanine4° (GA) is not bound to such anti-idiotype columns, in concordance with the absence of CGAT idiotype in anti-GA antibodies (9) . Further, it is demonstrated that the active TsF recovered from the anti-CGATimmunoadsorbents still possesses I-J determinants. The limitations and implications of these findings are discussed with respect to the possible structure of GAT-TsF and other antigen specific T-cell products. Antigens. GAT (lot 6, mol wt 32,500) was obtained from Miles Laboratories Inc., Miles
Materials and Methods
Research Products, Elkhart, Ind. and GA (lot 1, mol wt 36,000) was purchased from New England Nuclear, Boston, Mass. All antigen solutions, conjugates with methylated bovine serum albumin (MBSA), GAT-sheep erythrocytes (GAT-SRBC), and Sepharose-4B immunoadsorbents were prepared as previously described (4, 10) .
Preparation of Specific TsF.
Crude GAT-and GA-TsF were prepared as extracts of pooled spleens and thymuses of either DBA/I or SJL mice immunized i.p. 3-6 d previously with 100 p,g GAT or GA in aluminum-magnesium hydroxide gel (Maalox, William H. Rorer, Inc., Ft. Washington, Pa.) (1). These crude suppressor materials were then partially purified by adsorption onto and elution from either GAT-or GA-Sepharose columns, respectively (4). This procedure has been shown to remove a serologieally active fragment of GAT from the suppressor material bearing I region determinants, and was utilized to prevent possible interference by ligand (GAT) with binding of anti-CGAT antibody directed toward a combining site-associated idiotypic determinant.
Preparation and Characterization of Anti-CGA T Antiserum and Immunoadsorbents. The purification of anti-GAT antibodies and production of the anti-idiotypie antiserum have been detailed elsewhere (8) . Briefly, ascites fluid containing anti-GAT antibodies from D1.LP mice was precipitated with 40% ammonium sulfate. The y-globulin fraction was passed through a Sepharose 4B column to which an anti-H-2 b antiserum [(B10.A × A)Fx anti-B10] was coupled and then passed over a GAT immunoadsorbent. The anti-GAT antibodies were then eluted with an acid buffer and used to immunize guinea pigs. The resulting guinea pig anti-idiotypic serum was rendered specific for anti-GAT idiotypic determinants by precipitation, then adsorption with normal mouse immunoglobulins. The specific anti-idiotypic serum or control normal guinea serum was then coupled to CNBractivated Sepharoe 4B (Pharmacia, Uppsala, Sweden)• All immunoadsorbents contained approximately 2 mg of protein per milliliter of packed beads• Affinity Chromatography of GAT-and GA-TsF. All manipulations were carried out at 4°C. Small (0.3-0.5 ml) columns of either anti-CGAT-Sepharose or control normal guinea pig serum (NGPS)-Sepharose were washed extensively with phosphate-buffered saline (PBS), pH 7.2, then loaded with 1 ml purified GAT-TsF or GA-T~F. The T,F was run into the gel over a 1-min period, and allowed to incubate for 60-90 min, then a 2-bed volume PBS wash collected and termed filtrate. The columns were then washed with at least 10-bed volumes of PBS and the adsorbed material eluted over a 30-s period with 2-bed volumes of pH 2.5 glycine-HCl buffer. This collected material was rapidly neutralized with 1 N NaOH and termed eluate. All filtrates and eluates were stored at -20°C in small aliquots and thawed only once, immediately before use. In one series of experiments, the eluate of an anti-CGAT immunoadsorbent loaded with SJL GAT-TsF was passed over an anti-I-J 8 [(3R × 9R)F1 anti-B10.HTT]-Sepharose column and both the filtrate and eluate assayed for suppressive activity. All factor dilutions are calculated based on 6 × 10 s cells/ml as neat TsF, and assuming all T,F applied to a column to be present in any given filtrate or eluate.
Assay of T,F Activity. All assays for GAT-T~F and GA-TsF activity before and after immunoadsorbent passage were performed in vitro according to previously described techniques (6, 7) . In certain experiments, factors and column fractions were tested directly by addition to modified Mishell-Dutton cultures ofsyngeneic or allogeneic nonresponder spleen cells, by using GAT-MBSA or GA-MBSA as stimulating antigens. In other experiments, factors and column fractions were added to cultures of BALB/c responder spleen cells and incubated for 2 d to permit induction of suppressor cells (T~) (7). These precultured cells were then washed and added in graded numbers to fresh cultures of syngeneic BALB/c spleen cells with GAT as antigen. All cultures were harvested and assayed for specific IgG PFC on day 5, by using a modified Jerne plaque assaay with GAT-SRBC as indicator cells. Data are expressed as either specific PFC per (7.5 × 10 cell) culture or response in presence of specific TsF orT~ as percent control response = X 100%. response in presence of control T,F or cells
Results
Binding of SJL and DBA/1 GA T-TsF to Anti-CGA T-Immunoadsorbents. Partially purified GAT-TsF from either in vivo immunized SJL or DBA/1 nonresponder mice was prepared with a GAT-immunoadsorbent. These purified suppressor factors were then applied to either anti-CGAT or control (NGPS)-immunoadsorbents, and the filtrates and eluates tested for activity directly on nonresponde'r spleen cells cultured with GAT-MBSA as antigen. Figs. 1 and 2 present the results of several similar experiments. Fig. 1 demonstrates that virtually all the suppressive activity of SJL and DBA/1 GAT-T~F is removed by passage over anti-CGAT-immunoadsorbents and that the adsorbed TsF can be fully recovered in the acid eluate of such a column. Further, these experiments reveal that both the original purified GAT-T~F and the anti-CGAT adsorbed material can suppress not only syngeneic, but also allogeneic nonresponder spleen cells, in agreement with previous data (5). Fig. 2 summarizes a large number of similar experiments assaying immunoadsorbent treated DBA/1 GAT-TsF preparations on SJL spleen cells in culture. These data are all in agreement with those of Fig. 1 . The experiments in Figs. 1 and 2 were performed with several separately prepared batches of purified GAT-T~F, all of which gave identical results. Taken together, these data indicate that the directly suppressive component of nonresponder GAT-T~F is recognized and bound by immobilized antibody to CGAT determinants.
It is now appreciated that GAT-T~F acts at least in part by inducing virgin spleen cells (T cells) to become active suppressor cells (I'8 2) (6, 7). This induction ofTs 2 using nonresponder derived GAT-T~F can occur with syngeneic and allogeneic nonresponder, as well as allogeneic responder, spleen cells. To determine if the T~F responsible for this inducing activity was also recognized by anti-CGAT antibodies, the same filtrate and eluate materials assayed above in direct culture were used for T~ generation. BALB/c responder spleen cells were cultured for 2 d with various T~F preparations and these cultured cells then washed and added in varying numbers to fresh BALB/e cultures stimulated by GAT. Data from one of four experiments of this type, all of which gave similar results, are presented in Fig. 3 . Again, as for the direct acting material, the inducing GAT-T~F was completely removed by the anti-CGATimmunoadsorbent and could be recovered from the gel by acid elution. Thus, the material(s) in GAT-TsF responsible for both direct suppression of nonresponder 
DBA/I GA-T~F Fails to Bind to Anti-CGAT-Imrnunoadsorbents.
We have previously demonstrated that the CGAT idiotype is absent from mouse antibodies induced by the related copolymer GA (9) . This finding suggested the possibility that GA-TsF might lack CGAT-determinants and thus serve as an appropriate specificity control for the anti-CGAT column. Therefore, GA specific TsF was prepared from DBA/1 mice, and purified on GA-Sepharose. This material was then passed over control or anti-CGAT-immunoadsorbent columns and tested in culture with DBA/1 spleen cells and GA-MBSA. Table I presents one such experiment. DBA/1 GAT-TsF run in parallel with the GA-T~F was fully adsorbed onto and recovered from the anti-GATimmunoadsorbent, as shown repeatedly above. However, no significant binding of GA-T~F to the anti-CGAT-immunoadsorbent occurred. These data imply that the interaction of GAT-T~F with anti-CGAT antibodies is not due to a nonspecific affinity of this material for T~F bearing I region determinants nor is it likely to be merely a reflection of charge effects resulting from the large glutamic acid content of GAT, because a similar effect would be expected with GA-specific T,F as well.
Presence of Both CGA T Idiotypic Determinants and I-J 8 Determinants on GA T-T~F. GAT-T~F has been shown to bear I region, more specifically, I-J subregion controlled determinants (2, 3) . It was therefore of interest to determine if the anti-idiotype reactive suppressor material studied above also possessed such I-J determinants. To answer this question, the active eluate of an anti-CGAT column loaded with SJL (Ijs) GAT-T~F was passed over an anti-I-J ~ Sepharose immunoadsorbent. Table II details the results obtained with the parent materials and the alloantiserum adsorbed T~F. It is clear that the factor responsible for suppressive activity in the anti-CGAT eluate also possesses I-J ' determinants. Discussion The experiments presented above represent a first approach to the understanding of the nature of the antigen combining site on specific T-cell-derived suppressor factors. The results indicate that GAT-specific T~F can be adsorbed by and eluted from immunoadsorbents prepared from a guinea pig anti-idiotype antiserum recognizing a common (cross-reactive) determinant found on most murine anti-GATantibodies. This adsorption appears to be related to the antigen binding specificity of the TsF, because GAT-T,F but not GA-T,F, can be adsorbed by anti-CGAT-immunoadsorbents. Both direct suppressive activity on nonresponder spleen cells, and T~ inducing potential with responder spleen cells are selectively retained by anti-CGAT columns, and the active CGAT+GAT-T~F eluted from such a column still possesses I-J determinants. Further, the data indicate that the great majority of GAT-T,F molecules bind to anti-CGAT-immunoadsorbents, based on the virtually complete removal of suppressive activity on the anti-CGAT immunoadsorbent.
Investigation of the fine antigen specificity of antibodies bearing the CGAT idiotype has revealed that antibodies elicited by GAT and L-glutamic acidS°-L-tyrosine 5° (GT), but not GA, possess CGAT determinants, and that the idiotype from GAT induced antibodies preferentially bound to GT, rather than to GA. 2 These data imply that CGAT determinants are related to an antigen combining site specific for GAT or GT, but not GA, and that not all antibodies reactive with highly anionic polypeptides are bound by anti-CGAT antisera. Similar results were obtained with GAT-T~F versus GA-T~F in this study. The question still remains as to whether or not GT-T,F is CGAT ÷. The serological data might lead one to predict that GT-T~F would be CGAT ÷, but the lack of cross-suppression shown by GAT-T~F and GT-T~F in vitro (7) is difficult to reconcile with this hypothesis. Tests of GT-T~F binding to anti-CGAT-immunoadsorbents are under way to resolve this question. Although the most likely interpretation of the data presented in this paper is that GAT-TBF shares (a) combining site(s) with anti-GAT antibodies (i.e., possesses at least a part of an immunoglobulin V region), certain limitations of these experiments must be made clear. Although the starting immunogen consisted of (NH4)2SO4 fractionated, GAT affinity column purified antibodies that were also passed over an anti H-2 b imrnunoabsorbent in an effort to remove I-region coded T-cell products, it is still theoretically possible that the anti-CGAT-serum contains antibodies made directly to GAT-specific T-cell products which copurified with the immunoglobulins and were not removed by the anti-H-2 column. Responder mice are known to be capable of producing GAT-TsF, 3 and Kontiainen et al. have reported preparation of antiidiotype-like antisera to antigen purified TsF given in trace amounts according to immunization protocols similar to those used to raise anti-CGAT antisera (11) . The involvement of such putative anti-T-cell factor antibodies in studies of anti-idiotypic reactivity ofT-cell products is also a possibility in the earlier helper factor experiments of Mozes (12) , in which no attempt was made to remove I-coded materials from the immunogen. However, if such anti-T-cell product antibodies exist in the anti-CGAT reagent, they are not directed against mouse T~F as a class because GA-T~F is not bound by anti-CGAT columns. Rather, they must resemble immunoglobulin specific anti-CGAT antibodies in that they detect GAT specific products obtained from strains differing at both H-2 and Ig-1 loci. To resolve this issue, we are now cloning B-cell hybridomas secreting CGAT + antibodies to provide immunoglobulin material free of potential T-cell products. 4 These pure antibodies will then be used to absorb the anti-CGAT antiserum to determine whether or not it is antibody to immunoglobulin which actually binds the T-cell-derived GAT-T,F. If, as is likely, it is antibody to idiotypic determinants on anti-GAT antibodies that bind GAT-T,F, then several possible interpretations of the structural relationship between the binding regions of GAT-T~F and antibody may be considered. Because of the high frequency and broad representation of CGAT determinants on anti-GAT antibodies of not only mice, but other species such as the rat (9), it is clear that there has been extensive evolutionary conservation of a major GAT binding site. Therefore, the combining region of the GAT-TsF may have arrived at a configuration similar to immunoglobulin V regions by convergent evolution of independent genetic units, one in the MHC (for T~F) and the other in the Ig germ line V genes. Because of the absence of CGAT-mouse strains, it is not possible to rule out this interpretation on a genetic basis. However, it is not unreasonable to assume that if both GAT-T~F and anti-GAT immunoglobulin possess similar or identical idiotypic specificities, that they are coded for by the same genes, i.e., Ig V region genes. Such a model is consistent with the growing data on the presence of shared idiotypic specificities on B cells or Ig and T cells or T-cell products. These data include the studies of Binz and Wigzell on antibodies and T cells specific for allo-MHC determinants (13) and immunoglobulin? Rat T-cell products specific for alloantigens, as studied by Binz and Wigzell, possess idiotypes in common with antibodies of the same specificity (13), but both genetic and serologic studies found no evidence of MHC association with these T-cell materials (19) . On the other hand, Krammer and Eichmann found the idiotypic pattern of alloreceptors on mouse T lymphocytes can be influenced genetically by both Ig allotype and MHC linked loci, though the presence of either type of gene product in the actual receptor was not demonstrated (20) . The present study clearly suggests a physiochemical association of both MHC (I-J) coded products and V region determinants in the GAT-T~F. A minimal model incorporating the bulk of these and other related data would postulate that T cells produce materials with shared Ig V region determinants, presumably reflecting the presence of true Ig V region gene products. These V region products are either (a) part of a single chain also including I region coded material in which the V region portion provides antigen binding specificity and the I region portion provides biologic effector function (e.g., help, suppression, H-2 restricted cell-cell communication) in a manner similar to Ig Fc regions or (b) joined by disulfide or noncovalent bonds to a second chain containing the I region material, forming a tightly bound molecular complex with a similar distribution of functions. This model would provide a single explanation for certain Ir gene effects in terms of both cell interaction and factor activity in that lack of formation or functional expression of the proper I region-V region complex would preclude T-cell activity for the given antigen specificity of the V region and the particular I region effector function involved. Further, this model can accommodate either an altered self concept of T-cell antigen recognition, based on appropriate V region selection and/or mutation, or a dual receptor model involving recognition of a phy.sically linked nominal antigen and H-2 interaction site. Current advances in biochemical analysis of T-cell idiotype positive material will provide evidence for or against this model in the near future. Towards this end, the development of T hybridomas producing large quantities of active specific suppressor factor will provide an important tool, and efforts are underway to derive such hybridomas producing CGAT + GAT-T~F to be studied in parallel with the monoclonal CGAT ÷ anti-GAT antibodies now being isolated.
Summary
T-cell derived suppressor factors (T~ w) specific for the random copolymers Lglutamic acidn°-L-alanine~°-L-tyrosinel° and L-glutamie acid6°-L-alanine 4°, referred to as GAT and GA, respectively, were prepared and partially purified on the appropriate antigen immunoadsorbents. GAT-TsF obtained from nonresponder DBA/1 (H-2 q) and SJL (H-2 s) mice were passed over immunoadsorbents prepared from normal guinea pig serum (NGPS) or guinea pig anti-idiotype antiserum (anti-CGAT) specific for a common cross-reactive idiotype found on most anti-GAT antibodies in all mouse strains tested. Both the directly suppressive activity of the GAT-TsF and the ability of GAT-TsF to induce new suppressor T cells (-l', 2) in vitro were adsorbed to and fully recoverable from the guinea pig anti-CGAT-Sepharose immunoadsorbent, while the TsF passed through the control NGPS-Sepharose without appreciable binding. The SJL GAT-T~F specifically eluted from anti-CGAT-immunoadsorbents was shown to still possess I-J determinants. These data provide evidence suggesting a sharing of V region structures between B-cell antibody and T-cell suppressor factor specific for an antigen (GAT) under Ir gene control, in agreement with earlier studies on T and Bcell alloreceptors, T-cell helper factors, and T and B-cell receptors for conventional antigens.
